Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Accumulated Expenses (2021 - 2022)

Senti Biosciences (SNTI) has 2 years of Accumulated Expenses data on record, last reported at $4.0 million in Q1 2022.

  • For Q1 2022, Accumulated Expenses rose 1077.0% year-over-year to $4.0 million; the TTM value through Mar 2022 reached $4.0 million, up 1077.0%, while the annual FY2021 figure was $3.1 million, N/A changed from the prior year.
  • Accumulated Expenses reached $4.0 million in Q1 2022 per SNTI's latest filing, up from $3.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $4.0 million in Q1 2022 and bottomed at $2347.0 in Q2 2021.